| Q33899068 | A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues |
| Q36836937 | Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome |
| Q54263329 | Analysis of epigenetic modifications of DNA in human cells. |
| Q36648767 | Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma |
| Q36844969 | Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers |
| Q45889426 | Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma |
| Q55400516 | CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer. |
| Q46801734 | CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci |
| Q37280956 | DNA methylation in circulating tumour DNA as a biomarker for cancer |
| Q36213267 | DNA methylation profiles and biomarkers of oral squamous cell carcinoma. |
| Q37963517 | DNA methylation testing and marker validation using PCR: diagnostic applications. |
| Q61283947 | DNA methylation: Bisulphite modification and analysis |
| Q38901697 | Detection of MGMT promoter methylation in glioblastoma using pyrosequencing |
| Q38875094 | Detection of MGMT promoter methylation in glioblastoma using pyrosequencing. |
| Q36414343 | E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines |
| Q39453522 | Epigenetic biomarkers in the diagnosis of ovarian cancer. |
| Q37453787 | Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis |
| Q58569334 | Highly sensitive detection of DNA hypermethylation in melanoma cancer cells |
| Q34654655 | Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma |
| Q59799440 | Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR) |
| Q37201885 | Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing |
| Q34720314 | Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation. |
| Q35827916 | MGMT testing allows for personalised therapy in the temozolomide era. |
| Q36050701 | Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes |
| Q24628888 | MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index |
| Q37081967 | Molecular sputum analysis for the diagnosis of lung cancer |
| Q39528057 | Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. |
| Q42738436 | Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis |
| Q28731328 | Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma |
| Q58766022 | Pyrosequencing Analysis of Promoter Methylation in Meningioma |
| Q33520069 | Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM |
| Q33548990 | Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids |
| Q51022828 | Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid. |
| Q36135415 | Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma |
| Q36594150 | The epigenetic landscape of oral squamous cell carcinoma |
| Q53265228 | UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. |
| Q37699106 | Understanding oral cancer in the genome era. |
| Q55443705 | [The next generation sequencing technology and its application in cancer research]. |